Close Menu
  • News
  • Bitcoin
    • Lightning Network
  • Metaverses and NFT
  • Artificial Intelligence
  • Opinions
    • Crypto Regulations
    • Layer 2
    • On-chain Analysis
    • Trading
  • Tutorial
  • Italiano
  • English
Facebook X (Twitter) Instagram
SEGUICI
BlockWorld.it
  • News
  • Bitcoin
    • Lightning Network
  • Metaverses and NFT
  • Artificial Intelligence
  • Opinions
    • Crypto Regulations
    • Layer 2
    • On-chain Analysis
    • Trading
  • Tutorial
  • Italiano
  • English
Telegram X (Twitter)
BlockWorld.it
Home » News » Hyperliquid launches Hype and signs 888 million deal with Sonnet BioTherapeutics

Hyperliquid launches Hype and signs 888 million deal with Sonnet BioTherapeutics

Hyperliquid unveils Hype, its active on-chain strategy, and unveils a billion-dollar deal with Sonnet BioTherapeutics to tokenize rights to future biotech revenues.
RedazioneBy Redazione16 July 2025
Telegram Twitter WhatsApp Facebook
CONDIVIDI
Telegram Twitter WhatsApp Facebook

The Hyperliquid protocol is rewriting the rules of the game, and this time it is doing it in style. With the announcement of the new ‘Hype’ vault, an active and transparent on-chain strategy, the team is sending a direct message to the DeFi world: innovation is not just code, it is also vision. But the real news that has been rattling the desks of analysts and venture capitalists is another: Hyperliquid has just signed an $888 million deal with Nasdaq-listed biotech company Sonnet BioTherapeutics to tokenize part of their future commercial revenue.

The move is sensational. Under the deal, future rights to revenues from a pipeline of drugs will be digitally represented through ‘Hype Points’, financial instruments that will be tradable directly on Hyperliquid’s chain. It is the fusion of decentralised finance and real-world assets, where tokenization meets biotech in a dance of high potential. The assets will be ‘backed by revenue rights’, a formula that could open the door to a whole new market for DeFi, with regulated tokenized assets moving like derivatives within permissionless architectures.

Meanwhile, Hype, the new core product, is set up as a strategy vault where management is human, active and transparent. An on-chain hedge fund, we might say, with public access. The strategies employed concern directional and arbitrage operations, with a particular focus on assets such as Bitcoin and Ethereum, instruments that are now essential even for those operating on the fringes of the biotech or speculative sectors.

Hyperliquid, with Hype and the Sonnet deal, is not just looking for yield. It is demonstrating that the next frontier of decentralised finance is the ability to integrate real-world assets with crypto-native derivative instruments. And it is doing so with a symbolic figure, 888 million, that smacks of luck, speculation and oriental vision. It is not just a numbers game: it is a declaration of war on the borders between traditional finance and DeFi.

Here is the source: https://www.theblock.co/post/362417/hyperliquid-strategies-hype-treasury

Share. Telegram Twitter WhatsApp Facebook

Potrebbero interessarti anche

Strive buys 3,311 Bitcoin as competition in the market intensifies

16 October 2026

Odyssey 3: the world model that generates interactive worlds in real time

14 October 2026

Ether ETFs have been falling for nine days; Solana’s record inflows come to an end

11 October 2026
Telegram X (Twitter)
  • HOME
  • Staff
  • Contact us
  • Disclaimer
  • Cookie Policy
  • Privacy Policy
© 2026 BlockWorld.it proprietà di Digital Dreams s.r.l. - Partita IVA: 11885930963 - Sede legale: Via Alberico Albricci 8, 20122 Milano Italy - info@digitaldreams.it

Type above and press Enter to search. Press Esc to cancel.